These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 15495068

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges.
    Parker H, Qureshi N, Ulph F, Kai J.
    BMC Health Serv Res; 2007 Dec 13; 7():203. PubMed ID: 18078504
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice.
    Kai J, Ulph F, Cullinan T, Qureshi N.
    Health Technol Assess; 2009 Nov 13; 13(57):1-82, iii. PubMed ID: 19948087
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
    Hussein N, Weng SF, Kai J, Kleijnen J, Qureshi N.
    Cochrane Database Syst Rev; 2018 Mar 14; 3(3):CD010849. PubMed ID: 29537064
    [Abstract] [Full Text] [Related]

  • 9. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
    Hussein N, Weng SF, Kai J, Kleijnen J, Qureshi N.
    Cochrane Database Syst Rev; 2015 Aug 12; 2015(8):CD010849. PubMed ID: 26264938
    [Abstract] [Full Text] [Related]

  • 10. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ, Haavisto A, Laxova A, Rock LZ, Farrell PM.
    Pediatrics; 2001 Apr 12; 107(4):699-705. PubMed ID: 11335747
    [Abstract] [Full Text] [Related]

  • 11. Sickle cell and cystic fibrosis carrier results.
    Nurs Child Young People; 2016 Oct 07; 28(8):21. PubMed ID: 27712319
    [Abstract] [Full Text] [Related]

  • 12. A systematic review of the effects of disclosing carrier results generated through newborn screening.
    Hayeems RZ, Bytautas JP, Miller FA.
    J Genet Couns; 2008 Dec 07; 17(6):538-49. PubMed ID: 18956236
    [Abstract] [Full Text] [Related]

  • 13. Newborn screening for cystic fibrosis.
    Merelle ME, Nagelkerke AF, Lees CM, Dezateux C.
    Cochrane Database Syst Rev; 2001 Dec 07; (3):CD001402. PubMed ID: 11686989
    [Abstract] [Full Text] [Related]

  • 14. Newborn screening for cystic fibrosis.
    Merelle ME, Lees CM, Nagelkerke AF, Dezateux C.
    Cochrane Database Syst Rev; 2000 Dec 07; (2):CD001402. PubMed ID: 10796782
    [Abstract] [Full Text] [Related]

  • 15. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
    Lewis S, Curnow L, Ross M, Massie J.
    J Paediatr Child Health; 2006 Sep 07; 42(9):533-7. PubMed ID: 16925540
    [Abstract] [Full Text] [Related]

  • 16. A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.
    Bombard Y, Miller FA, Barg CJ, Patton SJ, Carroll JC, Chakraborty P, Potter BK, Tam K, Taylor L, Kerr E, Davies C, Milburn J, Ratjen F, Guttmann A, Hayeems RZ.
    Genet Med; 2017 Apr 07; 19(4):403-411. PubMed ID: 27608173
    [Abstract] [Full Text] [Related]

  • 17. Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center.
    Wheeler PG, Smith R, Dorkin H, Parad RB, Comeau AM, Bianchi DW.
    Genet Med; 2001 Apr 07; 3(6):411-5. PubMed ID: 11715005
    [Abstract] [Full Text] [Related]

  • 18. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
    Tluczek A, Koscik RL, Farrell PM, Rock MJ.
    Pediatrics; 2005 Jun 07; 115(6):1692-703. PubMed ID: 15930234
    [Abstract] [Full Text] [Related]

  • 19. Antenatal cystic fibrosis carrier screening--whether, when and how?
    Miedzybrodzka Z, Haites N, Hall M, Templeton A, Marteau T, Dean J, Kelly K, Russell I.
    Paediatr Perinat Epidemiol; 1993 Oct 07; 7(4):368-75. PubMed ID: 8290376
    [Abstract] [Full Text] [Related]

  • 20. Frequency of high-quality communication behaviors used by primary care providers of heterozygous infants after newborn screening.
    Farrell MH, Christopher SA.
    Patient Educ Couns; 2013 Feb 07; 90(2):226-32. PubMed ID: 23194821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.